Thiol/Disulphide Homeostasis in Unexplained Infertility
NCT ID: NCT05628766
Last Updated: 2023-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
82 participants
OBSERVATIONAL
2022-11-30
2023-04-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serum Kisspeptin Levels in Infertile Women
NCT03018314
Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers
NCT06339476
Subclinical Hypothyroidism and Normogonadotropic Anovulation
NCT05782725
Ovarian Reserve and Matrix Metalloproteinases
NCT05443282
The Effect of the Ovarian Reserve on the Recurrent Pregnancy Loss
NCT03009370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Excessive accumulation of ROS can damage cells, proteins, DNA and lipids; therefore, ROS levels are regulated by antioxidant mechanisms in the organism. A shift in the direction of ROS in this balance is called oxidative stress (OS). ROS produced in the follicle have important roles in folliculogenesis and ovulation. Granulosa cells produce antioxidants to protect oocytes from the harmful effects of excess ROS. OS has been implicated as an etiopathogenetic factor in female infertility. The number of studies examining the role of OS in the etiopathogenesis of infertility has increased in recent years, and it has been suggested that increased OS and/or decreased antioxidant defense mechanisms may contribute to infertility-related conditions.
One of the defense mechanisms against OS in humans is the thiol redox reaction. The thiol consists of a sulfhydryl group, and under OS conditions these functional groups form reversible disulfide bridges. These bonds bring about functional and structural changes in proteins. Disulfide bonds are reduced to thiol groups through antioxidant mechanisms, thereby providing thiol/disulfide homeostasis. Thus, disulfide bridges are thought to be a marker of OS, while thiols are suggested to be members of the antioxidant system. Only one side of this equilibrium has been measured by Ellman (1979), whereas in recent years both sides of the thiol/disulfide equilibrium can be measured by the Erel and Neselioğlu assay method, allowing a full assessment of the thiol/disulfide status.
Dynamic thiol/disulfide homeostasis, a recently identified marker of OS, is thought to have critical roles in pathological processes in various vital processes such as folliculogenesis and ovulation.
n the literature review, there are studies investigating the relationship between infertility and oxidant/antioxidants. However, measurements require measuring a large number of parameters and many separate biomarkers. The thiol/disulfide balance is beneficial in terms of showing the oxidant/antioxidant balance in total. It was not possible to measure this balance simultaneously on both sides in the method measuring the thiol/disulfide balance by Newman in 1979. In recent years, it has become possible to measure the serum Thiol/disulfide balance bilaterally with the automatic spectrophotometric method described by Erel and Neşelioğlu. This study aims to investigate whether there is a relationship by measuring the Total oxidant/antioxidant load with the Thiol/disulfide method in patients with unexplained infertility, to investigate the relationship between thiol/disulfide homeostasis and impaired ovulation and fertility, and to analyze the potential pathogenetic mechanism.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women diagnosed with primary infertility (n:41)
Women which followed up with infertility of unknown cause.
complete blood count
Thiol/disulphide levels in the blood will be checked by taking complete blood count
Control group ( n:41)
Healthy women who are not infertile
complete blood count
Thiol/disulphide levels in the blood will be checked by taking complete blood count
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
complete blood count
Thiol/disulphide levels in the blood will be checked by taking complete blood count
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients between the age of 18-35
Exclusion Criteria
* Chronic liver or kidney failure history
* Coronary artery disease
* Acute infection (within 14 days)
* Any chronic inflammatory disease
* Presence of autoimmune disease
* Known malignancy
* Inflammatory bowel disease
* Hormonal contraception
* Smoking
* alcohol use
* Drug use
* Patients with tubal infertility
* Partner with abnormal spermiogram
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Siirt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Serif Aksin
associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Şerif Aksin, assoc.Prof
Role: STUDY_DIRECTOR
Siirt University Medical Faculty Obstetrics and Gynecology Departmant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Siirt Üniversity Medical Faculty
Siirt, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SiirtUNIVERSI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.